Top Pharma News
  • Home
  • Pharma Release
  • Pharma News
  • Healthcare
  • Science
  • About Us
  • Contact Us
  • Our Team
  • Privacy Policy
  • Become a Contributor
Top Pharma News
  • Home
  • Pharma Release
  • Pharma News
  • Healthcare
  • Science
Author

Stephen Riddle

Stephen Riddle

Stephen is a top-notch and professional content writer at TopPharmaNews.com. He primarily focuses on news related to the Pharma News Field, particularly the groundbreaking discoveries taking place in the sector. It includes various clinical researches, findings, along with some happenings in the Pharma field. Additionally, he is an editorial assistant at the site. Thus, he keeps track of the news being published on TopPharmaNews.com.

  • Pharma News

    Leveraging KOL insights to succeed in a data-driven world

    by Stephen Riddle May 26, 2022
    by Stephen Riddle May 26, 2022

    For years, key opinion leaders (KOLs) have held a position of authority and respect amongst…

    Read more
  • Pharma News

    Biotech founder arrested in US amid murder-for-hire investigation

    by Stephen Riddle May 26, 2022
    by Stephen Riddle May 26, 2022

    The co-founder of Los Angeles biotech Enochian Biosciences has been arrested in connection with a…

    Read more
  • Pharma News

    FDA clears new first-line use for Servier’s Tibsovo in AML

    by Stephen Riddle May 26, 2022
    by Stephen Riddle May 26, 2022

    Servier is on course to get a return on its $1.8 billion takeover of Agios…

    Read more
  • Pharma News

    Lilly sets aside $2.1bn for domestic investments

    by Stephen Riddle May 26, 2022
    by Stephen Riddle May 26, 2022

    Eli Lilly’s home state of Indiana is set to benefit from a massive $2.1 billion…

    Read more
  • Pharma News

    How automatization keeps drug safety in war-torn Ukraine

    by Stephen Riddle May 26, 2022
    by Stephen Riddle May 26, 2022

    Ukrainian pharmaceutical companies are struggling to perform their duties in pharmacovigilance as Russia launched a…

    Read more
  • Pharma News

    Cumulus puts its digital biomarkers for CNS diseases to the test

    by Stephen Riddle May 26, 2022
    by Stephen Riddle May 26, 2022

    Cumulus Neuroscience has started a pair of clinical trials to gauge the value of a…

    Read more
  • Pharma News

    Why are clinical trials struggling with diversity?

    by Stephen Riddle May 26, 2022
    by Stephen Riddle May 26, 2022

    In the diverse world we live in, the products we produce, the services we create…

    Read more
  • Pharma News

    Angle claims FDA okay for Parsortix liquid biopsy system

    by Stephen Riddle May 25, 2022
    by Stephen Riddle May 25, 2022

    After more than six years of development, Angle has scored an FDA approval for Parsortix…

    Read more
  • Pharma News

    Third FDA rejection for Verrica’s molluscum contagiosum drug

    by Stephen Riddle May 25, 2022
    by Stephen Riddle May 25, 2022

    Shares in US biotech Verrica Pharma lost half their value today after the FDA declined…

    Read more
  • Pharma News

    Pfizer’s Arena buyout looks canny, as etrasimod aces phase 3 trials

    by Stephen Riddle May 25, 2022
    by Stephen Riddle May 25, 2022

    Pfizer placed a $6.7 billion bet on the outcome of two phase 3 trials of…

    Read more
  • Pharma News

    NICE finds solution to making Keytruda available for TNBC

    by Stephen Riddle May 25, 2022
    by Stephen Riddle May 25, 2022

    Around 100 patients in England and Wales with triple negative breast cancer (TNBC) that has…

    Read more
  • Pharma News

    Top 5 takeaways from international hybrid and virtual meeting guidance for pharma

    by Stephen Riddle May 25, 2022
    by Stephen Riddle May 25, 2022

    This post was originally published on Source Link

    Read more
  • Pharma News

    Dermavant claims its first approval as FDA clears psoriasis drug

    by Stephen Riddle May 25, 2022
    by Stephen Riddle May 25, 2022

    Roivant group company Dermavant has made the transition to a commercial-stage company after getting FDA…

    Read more
  • Pharma News

    Pfizer makes non-profit pledge for low-income nations

    by Stephen Riddle May 25, 2022
    by Stephen Riddle May 25, 2022

    US pharma giant Pfizer has said it will sell some of its patented medicines at…

    Read more
  • Pharma News

    Taking patient engagement efforts beyond box-ticking

    by Stephen Riddle May 25, 2022
    by Stephen Riddle May 25, 2022

    Most pharma and biopharma executives agree the patient voice should be at the centre of…

    Read more
  • Pharma News

    Rethinking value: why diverse viewpoints matter

    by Stephen Riddle May 24, 2022
    by Stephen Riddle May 24, 2022

    Value is a tricky concept to capture accurately. Given the diverse and complex world that…

    Read more
  • Pharma News

    [Webinar] Patient Centricity Drives Action: Research Supports Value of Social Health

    by Stephen Riddle May 24, 2022
    by Stephen Riddle May 24, 2022

    As healthcare evolves to become more consumer-centric, the value of social health – the dynamic,…

    Read more
  • Pharma News

    Nymox slumps as FDA rejects filing for prostate drug

    by Stephen Riddle May 24, 2022
    by Stephen Riddle May 24, 2022

    Shares in US biotech Nymox Pharma have plunged after the company announced the FDA had…

    Read more
  • Pharma News

    Second trial opens door for Lilly’s mirikizumab in ulcerative colitis

    by Stephen Riddle May 24, 2022
    by Stephen Riddle May 24, 2022

    Eli Lilly has the results it was looking for in a second, confirmatory trial of…

    Read more
  • Pharma News

    AbbVie adds to Vraylar data as FDA considers depression use

    by Stephen Riddle May 24, 2022
    by Stephen Riddle May 24, 2022

    AbbVie has reported new phase 3 data for its schizophrenia and bipolar disorder therapy Vraylar…

    Read more
  • Pharma News

    Pay deal averts strike action at GSK’s UK sites

    by Stephen Riddle May 24, 2022
    by Stephen Riddle May 24, 2022

    Industrial action at several GlaxoSmithKline manufacturing plants in the UK has been called off, after…

    Read more
  • Pharma News

    What does good cybersecurity look like in 2022?

    by Stephen Riddle May 24, 2022
    by Stephen Riddle May 24, 2022

    The pharma industry is becoming an increasingly hot commodity for cybercriminals. In recent years, digital…

    Read more
  • Pharma News

    Find your inner data and take precision marketing to the next level

    by Stephen Riddle May 24, 2022
    by Stephen Riddle May 24, 2022

    Data is the powerhouse of the pharmaceutical sector. It powers drug discovery, clinical trials, and…

    Read more
  • Pharma News

    Monkeypox cases are rising. Should we be worried?

    by Stephen Riddle May 24, 2022
    by Stephen Riddle May 24, 2022

    The World Health Organization has said the current outbreak of monkeypox is the largest ever…

    Read more
  • Pharma News

    Takeda, Daiichi-backed wearable study planned in Japan

    by Stephen Riddle May 23, 2022
    by Stephen Riddle May 23, 2022

    A study that will look at the feasibility of tracking people’s lifestyle habits for an…

    Read more
  • Pharma News

    USAID on expanding digital health globally – part two

    by Stephen Riddle May 23, 2022
    by Stephen Riddle May 23, 2022

    This article follows part one of our two-part series, in which we discussed how USAID…

    Read more
  • Pharma News

    Amwell’s SilverCloud buy yields new digital tool for mental health

    by Stephen Riddle May 23, 2022
    by Stephen Riddle May 23, 2022

    Telehealth company Amwell has marked Mental Health Awareness month with the launch of a digital…

    Read more
  • Pharma News

    Dupixent claims new territory in eosinophilic oesophagitis

    by Stephen Riddle May 23, 2022
    by Stephen Riddle May 23, 2022

    Sanofi and Regeneron have added another string to the bow of their immunology blockbuster Dupixent…

    Read more
  • Pharma News

    AbbVie files continuous Parkinson’s therapy ABBV-951 in US

    by Stephen Riddle May 23, 2022
    by Stephen Riddle May 23, 2022

    AbbVie has filed for approval of its therapy for Parkinson’s disease, ABBV-951, which promises continuous…

    Read more
  • Pharma News

    CHMP backs Sanofi’s Xenpozyme as first drug for ASMD

    by Stephen Riddle May 23, 2022
    by Stephen Riddle May 23, 2022

    Sanofi’s Genzyme unit has moved a step closer to securing EU approval for Xenpozyme –…

    Read more
  • Pharma News

    PTC gets green light for gene therapy Upstaza in EU

    by Stephen Riddle May 23, 2022
    by Stephen Riddle May 23, 2022

    PTC Therapeutic’s Upstaza  gene therapy for patients with genetic disorder AADC deficiency has been recommended…

    Read more
  • Pharma News

    Conducting successful commercial research in a primary care setting

    by Stephen Riddle May 20, 2022
    by Stephen Riddle May 20, 2022

    The primary care setting has garnered significant attention from industry stakeholders due to its promise…

    Read more
  • Pharma News

    On Clinical Trials Day, CVS shares lessons learned from one year providing trial services

    by Stephen Riddle May 20, 2022
    by Stephen Riddle May 20, 2022

    CVS Health has come a long way from its humble beginnings as a health and…

    Read more
  • Pharma News

    Bayer bails on $670m CAR-T partnership with Atara

    by Stephen Riddle May 20, 2022
    by Stephen Riddle May 20, 2022

    In February, Atara Biotherapeutics paused enrolment into a trial of a CAR-T cell therapy for…

    Read more
  • Pharma News

    Sidekick and Pfizer prep launch of DTx for atopic dermatitis

    by Stephen Riddle May 20, 2022
    by Stephen Riddle May 20, 2022

    A long-running partnership between digital therapeutics (DTx) developer Sidekick Health and Pfizer has resulted in…

    Read more
  • Pharma News

    Coalition aims to improve cancer drug access in poorer nations

    by Stephen Riddle May 20, 2022
    by Stephen Riddle May 20, 2022

    Several of the top pharmaceutical companies have joined a new coalition that aims to improve…

    Read more
  • Pharma News

    EU imposes Horizon funding block on UK scientists

    by Stephen Riddle May 20, 2022
    by Stephen Riddle May 20, 2022

    UK scientists are being denied from joining the €95 billion Horizon research funding programme as…

    Read more
  • Pharma News

    Sleepio app for insomnia backed by NICE

    by Stephen Riddle May 20, 2022
    by Stephen Riddle May 20, 2022

    After a non-committal appraisal of Big Health’s Sleepio app for insomnia last November in draft…

    Read more
  • Pharma News

    2nd Integrin-Targeted Drug Development Summit

    by Stephen Riddle May 19, 2022
    by Stephen Riddle May 19, 2022

    In collaboration with leading integrin drug developers, including Genentech, 7 Hills Pharma, and Pfizer, the 2nd Integrin-Targeted Drug Development…

    Read more
  • Pharma News

    How pharma can spur innovation and promote health equity in mental health: the pharmaphorum podcast

    by Stephen Riddle May 19, 2022
    by Stephen Riddle May 19, 2022

    In the newest episode of the pharmaphorum podcast, editor in chief Jonah Comstock speaks with…

    Read more
  • Pharma News

    Joined up thinking needed for joined up data plans

    by Stephen Riddle May 19, 2022
    by Stephen Riddle May 19, 2022

    Joined up data could transform the pharmaceutical industry and help create a healthier Europe for…

    Read more
  • Pharma News

    Targeted Radiopharmaceuticals Summit US (TRP US)

    by Stephen Riddle May 19, 2022
    by Stephen Riddle May 19, 2022

    The inaugural Targeted Radiopharmaceuticals Summit US  will bring together a worldwide community of specialists to address long-standing…

    Read more
  • Pharma News

    Large UK study suggests vaccination helps treat long COVID

    by Stephen Riddle May 19, 2022
    by Stephen Riddle May 19, 2022

    An observational study in the UK has found evidence that COVID-19 vaccination can help alleviate…

    Read more
  • Pharma News

    Beckley adds digital element to its psychedelic drug trials

    by Stephen Riddle May 19, 2022
    by Stephen Riddle May 19, 2022

    Phase 2 trials of Beckley Psytech’s psychedelic drug candidates will make use of digital technologies…

    Read more
  • Pharma News

    Moderna’s HIV vaccine prepped for trials in Africa

    by Stephen Riddle May 19, 2022
    by Stephen Riddle May 19, 2022

    Moderna has joined forces with non-profit organisation IAVI on a third phase 1 trial of…

    Read more
  • Pharma News

    Pharma bad boy Martin Shkreli is on the streets again

    by Stephen Riddle May 19, 2022
    by Stephen Riddle May 19, 2022

    Former pharma executive Martin Shkreli, who became notorious for raising the price of a lifesaving…

    Read more
  • Pharma News

    Merck snaps up cancer drug from China’s Kelun in $1.4bn deal

    by Stephen Riddle May 18, 2022
    by Stephen Riddle May 18, 2022

    Merck & Co has quietly added another drug to its immuno-oncology pipeline via an agreement…

    Read more
  • Pharma News

    KOL Validation: An Opportunity To Benchmark Mindset

    by Stephen Riddle May 18, 2022
    by Stephen Riddle May 18, 2022

    The benefits of conducting a regular KOL validation exercise to refresh your KOL list are…

    Read more
  • Pharma News

    SwanBio raises $56m for rare neurological disease gene therapy

    by Stephen Riddle May 18, 2022
    by Stephen Riddle May 18, 2022

    SwanBio Therapeutics has raised $56 million in a second-round financing that will be used to…

    Read more
  • Pharma News

    Digital health body publishes best practice guide for DTx developers

    by Stephen Riddle May 18, 2022
    by Stephen Riddle May 18, 2022

    Companies trying to bring digital therapeutic (DTx) products through development and onto the market have…

    Read more
  • 1
  • 2
  • 3
  • …
  • 17

Recent Posts

  • Leveraging KOL insights to succeed in a data-driven world

    May 26, 2022
  • Biotech founder arrested in US amid murder-for-hire investigation

    May 26, 2022
  • FDA clears new first-line use for Servier’s Tibsovo in AML

    May 26, 2022
  • Lilly sets aside $2.1bn for domestic investments

    May 26, 2022
  • How automatization keeps drug safety in war-torn Ukraine

    May 26, 2022
  • About Us
  • Contact Us
  • Our Team
  • Privacy Policy
  • Become a Contributor

@2018 - TopPharmaNews.com. All Right Reserved.